Citations

Clear

3138 citation(s) found for "Smith, AM".

Volumetric laser endomicroscopy and its application to Barrett's esophagus: results from a 1,000 patient registry
Smith, Michael S. , Konda, Vani J. , Gordon, Stuart R. , DeMeester, Steven R. , Joshi, Vivek , Ganguly, Eric K. , Mashimo, Hiroshi , Jobe, Blair A. , McKinley, Matthew , Wallace, Michael B. , Thakkar, Shyam , Schnoll‐Sussman, Felice , Sharaiha, Reem Z. , Tarnasky, P, Wolfsen, Herbert C. , Hawes, Robert H. , Lipham, John C. , Khara, Harshit S. , Navaneethan, U, Kedia, Prashant , Hasan, Muhammad K. , Sethi, Amrita , Samarasena, Jason , Siddiqui, Uzma D. , Gress, Frank G., Rodríguez, Reynaldo , Lee, C, Gonda, Tamas A. , Waxman, Irving , Hyder, S., Poneros, John M., Sharzehi, Kaveh , Palma, Jack A. Di, Sejpal, Divyesh V., Hagen, J. A., Rothstein, Richard, Sawhney, Mandeep , Malik, Zubair , Chang, Kenneth J. , Fichera, Alessandro , Gaidhane, Monica , Wallace, Michael B , Cash, Brooks D. , Trindade, Arvind J. , Diehl, David L. , Singh, Satish K. , Komatsu, Y, Kahaleh, Michel , Pleskow, Douglas K. , Hyder, S, Oh, Daniel S. , Berzin, Tyler M.

Mayo Clinic

Diseases of the Esophagus | April 30, 2019 | Volume: 32 | Issue: 9 | Pages: No page available

10.1093/dote/doz029 | PMID 31037293 Get It

SUMMARY Volumetric laser endomicroscopy (VLE) uses optical coherence tomography (OCT) for real-time, microscopic cross-sectional imaging. A US-based multi-center registry was constructed to prospectively collect data on patients undergoing upper endoscopy during which a VLE scan was performed. The objective of this registry was to determine usage patterns of VLE in clinical practice and to estimate quantitative and qualitative performance metrics as they are applied to Barrett's esophagus (BE) management. All procedures utilized the NvisionVLE Imaging System (NinePoint Medical, Bedford, MA) which was used by investigators to identify the tissue types present, along with focal areas of concern. Following the VLE procedure, investigators were asked to answer six key questions regarding how VLE impacted each case. Statistical analyses including neoplasia diagnostic yield improvement using VLE was performed. One thousand patients were enrolled across 18 US trial sites from August 2014 through April 2016. In patients with previously diagnosed or suspected BE (894/1000), investigators used VLE and identified areas of concern not seen on white light endoscopy (WLE) in 59% of the procedures. VLE imaging also guided tissue acquisition and treatment in 71% and 54% of procedures, respectively. VLE as an adjunct modality improved the neoplasia diagnostic yield by 55% beyond the standard of care practice. In patients with no prior history of therapy, and without visual findings from other technologies, VLE-guided tissue acquisition increased neoplasia detection over random biopsies by 700%. Registry investigators reported that VLE improved the BE management process when used as an adjunct tissue acquisition and treatment guidance tool. The ability of VLE to image large segments of the esophagus with microscopic cross-sectional detail may provide additional benefits including higher yield biopsies and more efficient tissue acquisition. Clinicaltrials.gov NCT02215291
A comparison of the natural history of oxaliplatin- and paclitaxel-induced neuropathy (NCCTG N08C1, N08CB/Alliance).
Ruddy, Kathryn J. , Pachman, Dierdre, Qin, Rui , Seisler, Drew K., Puttabasavaiah, Suneetha, Novotny, Paul J. , Ta, Lauren E., Beutler, Andreas S. , Wagner‐Johnston, Nina D. , Grothey, Axel, Dakhil, Shaker R. , Loprinzi, Charles L. , Lavoie Smith, Ellen M , Staff, Nathan P.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9564-9564

10.1200/jco.2015.33.15_suppl.9564 Get It

Results of a first-in-human, phase I/II trial of ASP2215, a selective, potent inhibitor of FLT3/Axl in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML).
Perl, Alexander E. , Altman, Jessica K. , Ritchie, Ellen K. , Baer, Maria R. , Litzow, Mark R. , Schiller, Gary J. , Üstün, Celalettin , Gill, Stan, Sargent, Briana, Bahceci, Erkut, Levis, Mark J. , Cortes, Jörge E. , Larson, Richard A. , Smith, Catherine C. , Wang, Eunice S. , Strickland, Stephen Anthony , Claxton, David F. , Liu, Charles Y.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7003-7003

10.1200/jco.2015.33.15_suppl.7003 Get It

0650 Normative EMG Values and Isolated Rapid Eye Movement Sleep Without Atonia Frequency in Adults without REM Sleep Behavior Disorder
Feemster, John, Jung, Jessica , Timm, Paul, Westerland, Sarah M., Teigen, Luke, Cattaneo, Elena F. D. , Imlach, C., Smith, Kevin L. , Silber, Michael H. , Gossard, Thomas , McCarter, Stuart J. , Smith, Kevin L, Boeve, Bradley F. , Louis, Erik K. St.

Mayo Clinic

Sleep | April 13, 2019 | Volume: 42 | Issue: Supplement_1 | Pages: A259-A259

10.1093/sleep/zsz067.648 Get It

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment
Evgin, Laura , Kottke, Timothy, Thompson, Jill , Molan, Amy M. , Driscoll, Christopher B. , Schuelke, Matthew , Shim, Kevin G. , Wongthida, Phonphimon , Ilett, Elizabeth J. , Smith, Karen Kaluza, Pulido, José S. , Pandha, Hardev , Selby, Peter J. , Harrington, Kevin J. , Melcher, Alan , Vile, Richard G. , Huff, Amanda L. , Shim, Kevin G , Ilett, Elizabeth J , Melcher, Alan A , Harrington, Kevin , Driscoll, Christopher , Harris, Reuben S. , Coffey, Matt C.

Mayo Clinic

Cancer Immunology Research | April 2, 2019 | Volume: 7 | Issue: 5 | Pages: 828-840

10.1158/2326-6066.cir-18-0013 | PMID 30940643 Get It

Abstract Antitumor T-cell responses raised by first-line therapies such as chemotherapy, radiation, tumor cell vaccines, and viroimmunotherapy tend to be weak, both quantitatively (low frequency) and qualitatively (low affinity). We show here that T cells that recognize tumor-associated antigens can directly kill tumor cells if used at high effector-to-target ratios. However, when these tumor-reactive T cells were present at suboptimal ratios, direct T-cell–mediated tumor cell killing was reduced and the ability of tumor cells to evolve away from a coapplied therapy (oncolytic or suicide gene therapy) was promoted. This T-cell–mediated increase in therapeutic resistance was associated with C to T transition mutations that are characteristic of APOBEC3 cytosine deaminase activity and was induced through a TNFα and protein kinase C–dependent pathway. Short hairpin RNA inhibition of endogenous APOBEC3 reduced rates of tumor escape from oncolytic virus or suicide gene therapy to those seen in the absence of antitumor T-cell coculture. Conversely, overexpression of human APOBEC3B in tumor cells enhanced escape from suicide gene therapy and oncolytic virus therapy both in vitro and in vivo. Our data suggest that weak affinity or low frequency T-cell responses against tumor antigens may contribute to the ability of tumor cells to evolve away from first-line therapies. We conclude that immunotherapies need to be optimized as early as possible so that, if they do not kill the tumor completely, they do not promote treatment resistance.
Clinical Features and Outcomes of Emergency Department Patients With High-Sensitivity Cardiac Troponin I Concentrations Within Sex-Specific Reference Intervals
Sandoval, Yader , Sexter, Anne, Gunsolus, Ian L. , Schulz, Karen , Apple, Fred S. , Smith, Stephen W.

Mayo Clinic

Circulation | April 1, 2019 | Volume: 139 | Issue: 14 | Pages: 1753-1755

10.1161/circulationaha.118.038284 | PMID 30933618 Get It

129. RESPIRATORY INVOLVEMENT IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: CLINICAL AND SEROLOGICAL PREDICTORS OF LONG-TERM ASTHMA SEVERITY
Smith, R. Lane , Keogh, Karina A., Berti, Alvise , Cornec, Divi , Moura, Marta Casal , Dagna, Lorenzo , Specks, Ulrich

Mayo Clinic

Rheumatology | March 29, 2019 | Volume: 58 | Issue: Supplement_2 | Pages: No page available

10.1093/rheumatology/kez059.006 Get It

Methodological consensus on clinical proton MRS of the brain: Review and recommendations
Wilson, Martin , Andronesi, Ovidiu C. , Barker, Peter B. , Bartha, Robert , Bizzi, Alberto , Bolan, Patrick J. , Cudalbu, Cristina , Dydak, Ulrike , Emir, Uzay E. , González, R. Gilberto , Gruber, Stephan , Gupta, Rakesh K. , Henning, A , Hetherington, Hoby P. , Hüppi, Petra S. , Hurd, Ralph E. , Kantarci, Kejal , Kauppinen, Risto A. , Klomp, Dennis W. J. , Kreis, Roland , Kruiskamp, Marijn J., Leach, Martin O. , Lin, Alexander , Luijten, Peter R. , Marjańska, Małgorzata , Meyerhoff, Dieter J. , Mountford, Carolyn E. , Mullins, Paul G. , Murdoch, James B. , Nelson, Sarah J. , Noeske, Ralph , Öz, Gülin , Pan, Julie W., Poptani, Harish , Posse, Stefan , Ratai, Eva‐Maria , Salibi, Nouha , Scheenen, Tom W. J. , Soher, Brian J. , Tkáč, Ivan , Vigneron, Daniel B. , Howe, Franklyn A. , Choi, In‐Young , Kreis, Roland , Maudsley, Andrew A , Howe, Franklyn A , Öz, Gülin , Marjańska, Małgorzata , Kantarci, Kejal , Brindle, Kevin Michael , Choi, In‐Young, Gruetter, Rolf , Heerschap, Arend , Peet, Andrew C. , Smith, Ian C. P.

Mayo Clinic

Magnetic Resonance in Medicine | March 28, 2019 | Volume: 82 | Issue: 2 | Pages: 527-550

10.1002/mrm.27742 | PMID 30919510 Get It

Proton MRS (1H MRS) provides noninvasive, quantitative metabolite profiles of tissue and has been shown to aid the clinical management of several brain diseases. Although most modern clinical MR scanners support MRS capabilities, routine use is largely restricted to specialized centers with good access to MR research support. Widespread adoption has been slow for several reasons, and technical challenges toward obtaining reliable good‐quality results have been identified as a contributing factor. Considerable progress has been made by the research community to address many of these challenges, and in this paper a consensus is presented on deficiencies in widely available MRS methodology and validated improvements that are currently in routine use at several clinical research institutions. In particular, the localization error for the PRESS localization sequence was found to be unacceptably high at 3 T, and use of the semi‐adiabatic localization by adiabatic selective refocusing sequence is a recommended solution. Incorporation of simulated metabolite basis sets into analysis routines is recommended for reliably capturing the full spectral detail available from short TE acquisitions. In addition, the importance of achieving a highly homogenous static magnetic field (B0) in the acquisition region is emphasized, and the limitations of current methods and hardware are discussed. Most recommendations require only software improvements, greatly enhancing the capabilities of clinical MRS on existing hardware. Implementation of these recommendations should strengthen current clinical applications and advance progress toward developing and validating new MRS biomarkers for clinical use.